ProShare Advisors LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$48,102
-38.5%
15,319
+1.0%
0.00%
Q2 2023$78,257
+3.1%
15,166
+5.3%
0.00%
Q1 2023$75,930
+65.9%
14,408
-11.5%
0.00%
Q4 2022$45,758
-26.2%
16,284
+8.7%
0.00%
Q3 2022$62,000
+5.1%
14,986
+2.4%
0.00%
Q2 2022$59,000
-46.8%
14,633
-34.4%
0.00%
Q1 2022$111,000
-42.2%
22,316
-18.9%
0.00%
Q4 2021$192,000
-26.7%
27,532
+5.1%
0.00%
-100.0%
Q3 2021$262,000
-45.0%
26,185
-22.1%
0.00%0.0%
Q2 2021$476,000
-2.9%
33,594
+12.4%
0.00%
-50.0%
Q1 2021$490,000
-9.8%
29,885
+14.0%
0.00%0.0%
Q4 2020$543,000
+924.5%
26,216
+49.8%
0.00%
Q3 2019$53,000
-26.4%
17,500
+7.5%
0.00%
Q2 2019$72,000
+1.4%
16,280
-9.0%
0.00%
Q1 2019$71,000
+2.9%
17,889
+2.5%
0.00%
Q4 2018$69,000
-42.5%
17,445
+0.1%
0.00%
-100.0%
Q3 2016$120,000
+17.6%
17,423
-15.5%
0.00%
+100.0%
Q2 2016$102,000
-47.2%
20,623
+3.1%
0.00%
-66.7%
Q1 2016$193,000
-6.8%
20,009
-9.4%
0.00%0.0%
Q4 2015$207,00022,0780.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders